CGL
CELG

Clarius Group LLC’s Celgene Corp CELG Stock Holding History

Clarius Group LLC’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-4,593
Closed -$456K – 309
2019
Q3 		$456K Sell
4,593
-194
-4% -$18.4K 0.08% 129
2019
Q2 		$443K Buy
4,787
+1,265
+36% +$120K 0.09% 121
2019
Q1 		$332K Buy
+3,522
New +$308K 0.08% 131
2017
Q3 		– Sell
-1,576
Closed -$205K – 100
2017
Q2 		$205K Buy
+1,576
New +$193K 0.08% 89

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Clarius Group LLC's CELG Position: Q4 2019 in Review

Clarius Group LLC sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 4,593 shares — an estimated $456K sold.

Clarius Group LLC first reported a position in CELG in Q2 2017 and held it in 4 quarters. The position peaked at $456K in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Clarius Group LLC reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Clarius Group LLC sold 4,593 Celgene Corp shares in Q4 2019, an estimated $456K.
  • Clarius Group LLC first reported a position in Celgene Corp in Q2 2017 and held it in 4 quarters.
  • Clarius Group LLC's Celgene Corp position peaked at $456K in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Clarius Group LLC's 13F filing for Q4 2019, filed 22 Jan 2020.